Search

everythinglearnresearchcommunity

for

Search:↓

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Finasteride helps female-pattern hair loss.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

JAK inhibitors may reduce depression in people with alopecia areata.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

JAK inhibitors might help treat alopecia areata.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.